Research and Development

Slug
/research-and-development
Sections
Banner Image
Image
e22
Title
Our Capabilities
Number
8
Headline

Global R&D Sites across 4 countries

Countries
India
USA
Netherlands
UK
description

Our research sites host top scientific minds working to make health accessible worldwide.

Map Image
Image
47a
Stats
Stat value
R&D Scientists
Stat value
FTM launches in priority markets
Item
Headline

Our R&D Focus

description

At the core of our R&D prowess is the Integrated Product Development Organisation (IPDO), at Bachupally, Hyderabad, India. The expansive campus of IPDO houses several laboratories with the most recent being the Nutraceutical R&D centre. These labs, powered by a diverse talent pool of scientists from leading institutions around the world. \n\nOur product development efforts drive a portfolio of more than 1,000 products enabled by our robust R&D team consisting of more than 150 doctorates.

Headline

Future Focus

description

We run pioneering projects at the cutting edge of drug development across all technologies and dosage forms. Our team has expertise across therapeutic areas and geographies for generics as well as APIs, biosimilars, OTC drugs and other differentiated products.\n\nAlong with our deep and diverse expertise across chemistry, engineering, biology and formulations, we are also exploring advanced manufacturing technologies, measurement, analytics & controls, modelling & simulation and digital innovation.\n\nIn short, our R&D capabilities play a key role in fulfilling our promise of addressing unmet patient needs, bringing expensive medicines within reach and helping patients manage disease better.

Headline

Digital Science

description

Our Digital science initiative helps give impetus to our Research and Development effort with data and analytics use cases across the development cycle. These use cases are aimed at achieving significant reduction in drug development cycle time, improvement of bio study success rate, cost savings to enable First-to-Market products, accelerating the R&D timeline, etc.